Business & Tech
Sun Sets On GOP Insider Jay Lucas As He Pleads Guilty In $50M Fraud
Former GOP gubernatorial nominee and donor Jay Lucas guilty to securities fraud, wire fraud, money laundering, and investment adviser fraud.

Former Republican gubernatorial nominee and longtime GOP donor Jay Lucas may soon bring his Sunshine brand of positivity and optimism to federal prison after pleading guilty to operating a $50 million investment fraud.
Lucas, 71, pleaded guilty Friday in U.S. District Court for the Southern District of New York to securities fraud, wire fraud, money laundering and investment adviser fraud.
Find out what's happening in Portsmouthfor free with the latest updates from Patch.
“Lucas lied to investors to induce them into investing millions of dollars in private equity funds that he created, promising to invest their money in emerging companies in the health and wellness space,” said U.S. Attorney Jay Clayton. “In reality, Lucas used much of the money to pay for personal expenses and ventures entirely unrelated to the funds, and to make Ponzi-like payments to other investors.
“Today’s plea reflects the continued commitment of this Office and our law enforcement partners to holding accountable investment advisers who abuse their investors’ trust to illegally enrich themselves.”
Find out what's happening in Portsmouthfor free with the latest updates from Patch.
Lucas is a former two-term Republican state representative who was first elected at age 19 while attending Yale University. He was an alternate delegate to the 1976 Republican National Convention and later served as treasurer of the New Hampshire Republican State Committee.
In 1998, Lucas spent nearly $1 million of his own money to win the GOP gubernatorial nomination in a bitter primary against former state Sen. Jim Rubens. He went on to lose the general election to incumbent Democratic Gov. Jeanne Shaheen.
Lucas remained a major Republican donor and activist after his gubernatorial campaign and was mentioned as recently as 2020 as a possible GOP candidate for U.S. Senate. His son, Gates Lucas, represented Sullivan County as a Republican in the New Hampshire House from 2018 to 2020.
The securities fraud, wire fraud and money laundering charges each carry maximum prison sentences of 20 years. The investment adviser fraud charge carries a maximum sentence of five years. Lucas’ actual punishment will be determined at a sentencing hearing.
Lucas operated Lucas Brand Equity, a boutique investment firm that purported to focus on emerging companies in the health and wellness industry. Prosecutors say he instead used investors’ money to pay his rent and alimony, finance the Eagle Times newspaper, hire political consultants and cover other personal expenses.
The Securities and Exchange Commission also alleges Lucas used investor money to pay for his wedding reception.
Lucas concealed negative information about companies in which he claimed to be investing, including the fact that one had gone out of business, according to federal authorities. He also used money from new investors to make Ponzi-like payments to disgruntled earlier investors.
A separate SEC lawsuit filed in the Southern District of New York links the alleged fraud to Lucas’ relationship with his current wife, Karen Ballou.
Lucas took control of a skincare-products company in 2013, purchasing a 51 percent interest through his investment operation. He turned the company into Immunocologie and appointed Ballou, then his girlfriend and now his wife, as CEO.
Ballou has not been charged with any crime and is not accused of criminal wrongdoing in the case.
Her founder’s story, recounted in multiple health and wellness publications, focuses on her launching the business in 2014 after recovering from Hodgkin lymphoma. That account generally omits Lucas’ role in buying the skincare company with investor money and installing Ballou as CEO, as described in the SEC lawsuit.
Lucas’ investors did not own any part of Immunocologie, even though he told them their investments gave them an ownership stake, the SEC alleges. Instead, Lucas retained control while concealing both the company’s ownership structure and his romantic relationship with its CEO.
“At least one investor stated after the fact that he would have considered it essential to know that the CEO was Lucas’s wife before deciding to invest because that meant that the Fund’s large investment in Immunocologie posed a serious conflict of interest,” the SEC lawsuit states.
Lucas ultimately directed millions of dollars from the three investment funds he managed into Immunocologie.
“From about 2013 through 2018, [Lucas] directed more than $5.3 million of Fund 1 investor money to Immunocologie. From 2018 to 2024, [Lucas] directed more than $6.9 million of Fund 2 investor money to Immunocologie,” the lawsuit states.
Those transfers made Immunocologie the largest investment held by both funds, representing approximately 40 percent of Fund 1’s invested capital and 43 percent of Fund 2’s. Fund 3 transferred at least $310,000 to Immunocologie, representing approximately half of the money that fund invested in portfolio companies.
Lucas also moved investor money into an account for XL7 Group, an LLC he operated with Ballou, according to the SEC.
“[Lucas] operated [XL7] as a slush fund masquerading as a business account that he could tap for personal expenses,” the lawsuit states.
Lucas and Ballou married May 12, 2018, in a lavish ceremony allegedly financed in part with investor money.
Nine days before the wedding, a married couple investing with Lucas for the first time gave him $375,000. The entire investment was supposed to go into one of Lucas’ funds, but he instead transferred $123,000 to XL7, the SEC alleges.
Lucas then used $118,448 from the investor deposit to pay three vendors for his upcoming wedding. Around the same time, XL7 also paid $6,700 to a political consultant and $3,000 to one of Lucas’ family members, according to the lawsuit.
The investors who had handed Lucas $375,000 days earlier attended his wedding and reception.
“They were unaware that at least $123,000 of their investment had been diverted to pay many of the vendors for the events they were attending,” the lawsuit states.
Immunocologie was also a disastrous investment, according to the SEC. From 2018 through 2023, the company lost an average of more than $1 million annually.
Lucas nevertheless valued Immunocologie at more than $12 million in communications with investors, giving them the false impression that the company—and their investments—were generating substantial returns, the SEC alleges.
Immunocologie was just one example of Lucas using investors’ money for his own purposes. Prosecutors say he left his funds nearly broke, with none of his investors receiving actual returns.
“[N]one of the Funds’ investments have paid off, and no investors have received returns. The Funds and their portfolio companies have hemorrhaged cash and been unable to cover basic expenses while Lucas and his family have taken the Funds’ money to serve their own interests,” prosecutors said when Lucas was arrested in December.
One of Lucas’ most prominent purchases with misappropriated investor money was the Claremont-based Eagle Times.
Lucas bought the newspaper in 2022 through Sunshine Communications, presenting the acquisition as part of his “Sunshine Initiative” to revitalize his hometown of Newport and other struggling communities.
The Eagle Times stopped publishing last summer after most of its employees walked out amid delayed paychecks and unpaid bills that caused the newspaper’s telephone and internet services to be disconnected. Lucas tried briefly to keep the paper operating before suspending publication indefinitely, leaving Claremont without its longtime daily newspaper.
Prosecutors now describe the Eagle Times as a “vanity newspaper project” financed with money Lucas diverted from investors.
This story was originally published by the NH Journal, an online news publication dedicated to providing fair, unbiased reporting on, and analysis of, political news of interest to New Hampshire. For more stories from the NH Journal, visit NHJournal.com.